Forecasting Atelectasis in Pediatric Mycoplasma pneumoniae Pneumonia Using an Interpretable Machine Learning Approach with SHAP Analysis

Overview

This study evaluates the performance of machine learning models in predicting atelectasis risk in children with Mycoplasma pneumoniae pneumonia. The neural network model outperformed others, achieving an AUC of 0.89, while SHAP analysis identified key predictive variables.

Background

Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia in children, with a notable percentage progressing to severe complications like atelectasis. Early identification of atelectasis is crucial for timely intervention, as it can lead to prolonged hospital stays and long-term pulmonary issues. Traditional diagnostic methods have limitations, highlighting the need for innovative, non-invasive predictive tools.

Data Highlights

Key Findings

• The neural network model showed the best performance with an AUC of 0.89.
• KNN model achieved an AUC of 0.88, indicating comparable performance.
• The SVM model had the highest specificity at 0.87.
• SHAP analysis identified neutrophil percentage, serum amyloid A, and C-reactive protein as critical predictive variables.
• Machine learning models can effectively handle complex clinical data for risk prediction.
• Early identification of atelectasis can improve management and outcomes in pediatric patients.

Clinical Implications

The findings suggest that machine learning models, particularly neural networks, can enhance the early identification of atelectasis in pediatric Mycoplasma pneumoniae pneumonia. Clinicians can utilize these models to tailor interventions based on individual risk profiles, potentially improving patient outcomes.

Conclusion

This study highlights the potential of machine learning in predicting atelectasis risk in children with Mycoplasma pneumoniae pneumonia, offering a valuable tool for clinicians to improve early intervention strategies.

Related Resources & Content

1. Frontiers in Surgery, 2026 -- Perioperative machine learning models with SHAP interpretation for predicting adverse outcomes in breast cancer surgery
2. Frontiers in Pediatrics, 2026 -- Machine learning-based identification of inflammatory biomarkers for predicting pulmonary consolidation in children with Chlamydia pneumoniae infection
3. The Journal of Clinical Endocrinology & Metabolism -- Machine Learning Prediction of Recurrence in Pediatric Thyroid Cancer: Malignant Endocrine Tumors Cohort Analysis Using XGBoost and SHAP
4. Frontiers in Digital Health, 2026 -- Creation and validation of interpretable machine learning models for assessing the risk of pancreatic pseudocyst formation in acute pancreatitis patients
5. IDSA/PIDS 2026 Guidelines for the Management of Community-Acquired Pneumonia (CAP) in Infants and Children Older Than 3 Months of Age
6. Low-dose versus high-dose methylprednisolone for children with severe Mycoplasma pneumoniae pneumonia (MCMP): A randomized controlled trial - PubMed
7. SHAP based feature selection for machine learning prediction of mycoplasma pneumoniae pneumonia with atelectasis in children | BMC Pediatrics | Springer Nature Link
8. IDSA/PIDS 2026 Guidelines for the Management of Community-Acquired Pneumonia (CAP) in Infants and Children Older Than 3 Months of Age
9. Low-dose versus high-dose methylprednisolone for children with severe Mycoplasma pneumoniae pneumonia (MCMP): A randomized controlled trial - PubMed
10. SHAP based feature selection for machine learning prediction of mycoplasma pneumoniae pneumonia with atelectasis in children | BMC Pediatrics | Springer Nature Link